VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab

Rheumatology (Oxford). 2024 Mar 1;63(3):e110-e112. doi: 10.1093/rheumatology/kead536.
No abstract available

MeSH terms

  • Causality
  • Granulomatosis with Polyangiitis* / complications
  • Granulomatosis with Polyangiitis* / drug therapy
  • Humans
  • Infliximab / therapeutic use
  • Leukocyte Disorders*
  • Methotrexate / therapeutic use
  • Myelodysplastic Syndromes*
  • Skin Diseases, Genetic*

Substances

  • Infliximab
  • Methotrexate

Supplementary concepts

  • VEXAS syndrome